Time-of-day variation in cardiovascular response to maximal exercise testing in coronary heart disease patients

Monique Dufour Doiron1, Denis Prud'homme, Pierre Boulay

  • 1School of Kinesiology and Recreation, Faculty of Health Sciences, Université de Moncton, Moncton, NB, Canada.

Insights

Beta-blockers like atenolol and metoprolol show time-of-day variations in their effects on heart rate and blood pressure during exercise tests in coronary heart disease patients. Afternoon tests may reveal more accurate cardiovascular and ischemic responses.

Area of Science:

  • Cardiology
  • Pharmacology
  • Exercise Physiology

Background:

  • Beta-blockers are commonly prescribed for coronary heart disease (CHD).
  • The timing of medication intake can influence drug efficacy and patient response.
  • Understanding diurnal variations in cardiovascular response is crucial for optimizing exercise testing in CHD patients.

Purpose of the Study:

  • To investigate the impact of beta-blockers (atenolol, metoprolol) on exercise heart rate (HR) and rate pressure product (RPP).
  • To compare morning versus afternoon maximal exercise tests (maxET) in CHD patients on beta-blockers.
  • To identify potential time-of-day effects on cardiovascular and ischemic responses during exercise.

Main Methods:

  • Twenty-one CHD patients on atenolol or metoprolol underwent two symptom-limited maxETs.
  • Tests were conducted in the morning (2-3h post-medication) and afternoon (8-10h post-medication).
  • Exercise capacity, perceived exertion, HR, RPP, and electrocardiogram (ECG) responses were analyzed.

Main Results:

  • No significant differences in exercise capacity or perceived exertion were found between morning and afternoon tests.
  • Atenolol showed better HR and RPP control in the afternoon.
  • Metoprolol group had a significantly higher difference in morning vs. afternoon HRmax, with a trend for RPP.
  • Nearly 25% of patients with normal morning tests showed abnormal ECG/ischemia in the afternoon, more so with metoprolol.

Conclusions:

  • Significant time-of-day variations exist in cardiovascular responses to maxET in CHD patients on beta-blockers.
  • Afternoon exercise testing may provide a more sensitive assessment of cardiovascular and ischemic status.
  • These findings highlight the importance of considering medication timing in exercise stress testing protocols.

Related Concept Videos

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Exercise Stress Test01:26

Exercise Stress Test

Introduction
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Cardiac Output I:Effect of Heart Rate on Cardiac Output01:19

Cardiac Output I:Effect of Heart Rate on Cardiac Output

Cardiac Output
Cardiac output (CO) refers to the total amount of blood ejected by one of the ventricles in liters per minute (L/min). In a resting adult, CO ranges from 5 to 6 L/min, adjusting according to the body's metabolic requirements.
Effect of Heart Rate on Cardiac Output
Cardiac output adapts to metabolic demands during stress, physical activity, or illness. The autonomic nervous system regulates heart rate via the sinoatrial node. The parasympathetic nervous system decreases heart rate...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...